Skip to main content
. Author manuscript; available in PMC: 2015 Feb 20.
Published in final edited form as: Gynecol Oncol. 2012 Dec 21;129(1):173–178. doi: 10.1016/j.ygyno.2012.12.027

Table 3A.

Age- and European ancestry-adjusted Odds Ratios (OR) and 95% Confidence Intervals (CI) for associations between VDR variants and Ovarian Cancer among Caucasians

Cases Controls Age- and Ancestry-adjusted
All* Invasive** All All* Invasive**
N (%) N (%) N (%) OR (95%CI) OR (95% CI)
rs7975232 Apa1
AA 138 (27.2) 105 (26.8) 148 (27.8)
AC 262 (51.7) 204 (52.0) 261 (49.1)
CC 107 (21.1) 83 (21.2) 123 (23.1)
AC/CC 369 (72.8) 287 (73.2) 384 (72.2)
Log-additive 0.97 (0.82, 1.15) 0.97 (0.80, 1.17)
Total 507 392 532
rs2228570 Fok1
GG 197 (38.5) 158 (39.9) 203 (38.2)
AG 250 (48.8) 185 (46.7) 256 (48.2)
AA 65 (12.7) 53 (13.4) 72 (13.6)
AG/AA 315 (61.5) 238 (60.1) 328 (61.8)
Log-additive 0.98 (0.82, 1.17) 0.97 (0.80, 1.17)
Total 512 396 531
rs731236 Taq1
TT 168 (32.9) 131 (33.2) 198 (37.4)
TC 266 (52.1) 205 (51.9) 243 (45.8)
CC 77 (15.1) 59 (14.9) 89 (16.8)
TC/CC 343 (67.1) 264 (66.8) 332 (62.6)
Log-additive 1.06 (0.89, 1.27) 1.06 (0.88, 1.28)
Total 511 395 530
rs1544410 Bsm1
CC 165 (33.1) 129 (33.5) 192 (36.7)
CT 257 (51.6) 197 (51.2) 244 (46.7)
TT 76 (15.3) 59 (15.3) 87 (16.6)
CT/TT 333 (66.9) 256 (66.5) 331 (63.3)
Log-additive 1.05 (0.88, 1.25) 1.05 (0.87, 1.27)
Total 498 385 523
rs2239179
TT 142 (28.1) 111 (28.4) 168 (31.8)
TC 275 (54.3) 211 (54.0) 267 (50.5)
CC 89 (17.6) 69 (17.6) 94 (17.8)
TC/CC 364 (71.9) 280 (71.6) 361 (68.2)
Log-additive 1.08 (0.90, 1.29) 1.08 (0.89, 1.31)
Total 506 391 529
rs3782905
GG 214 (42.2) 171 (43.6) 243 (46.2)
GC 237 (46.7) 177 (45.2) 231 (43.9)
CC 56 (11.0) 44 (11.2) 52 (9.9)
GC/CC 293 (57.8) 221 (56.4) 283 (53.8)
Log-additive 1.13 (0.94, 1.36) 1.11 (0.91, 1.35)
Total 507 392 526
rs7968585
AA 132 (26.0) 101 (25.7) 144 (27.2)
AG 262 (51.6) 203 (51.7) 252 (47.5)
GG 114 (22.4) 89 (22.6) 134 (25.3)
AG/GG 376 (74.0) 292 (74.3) 386 (72.8)
Log-additive 0.97 (0.81, 1.15) 0.97 (0.81, 1.17)
Total 508 393 530
*

including all peritoneal cases

**

including serous invasive peritoneal cases